{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O15111",
      "entity_text" : "IkappaB kinase",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0490" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "Furthermore, treatment with t-BHQ, an activator of Nrf2, was observed to attenuate IIR induced tissue injury, mitigate intestinal barrier dysfunction, reduce proinflammatory cytokines and apoptotic factors, and inhibit IkappaB kinase / IkappaB phosphorylation and NF-kappaB nuclear translocation.",
  "reading_complete" : "2020-08-03T13:15:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:14:30Z",
  "trigger" : "phosphorylation",
  "evidence" : [ "IkappaB kinase/IkappaB phosphorylation" ],
  "pmc_id" : "5716448",
  "score" : 0
}